EnVVeno Research Development vs Selling General Administrative Analysis
NVNO Stock | USD 4.96 0.05 1.00% |
EnVVeno Medical financial indicator trend analysis is much more than just examining enVVeno Medical Corp latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether enVVeno Medical Corp is a good investment. Please check the relationship between EnVVeno Medical Research Development and its Selling General Administrative accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
Research Development vs Selling General Administrative
Research Development vs Selling General Administrative Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of enVVeno Medical Corp Research Development account and Selling General Administrative. At this time, the significance of the direction appears to have very strong relationship.
The correlation between EnVVeno Medical's Research Development and Selling General Administrative is 0.8. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of enVVeno Medical Corp, assuming nothing else is changed. The correlation between historical values of EnVVeno Medical's Research Development and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of enVVeno Medical Corp are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Research Development i.e., EnVVeno Medical's Research Development and Selling General Administrative go up and down completely randomly.
Correlation Coefficient | 0.8 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Research Development
Selling General Administrative
Most indicators from EnVVeno Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into enVVeno Medical Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. As of the 29th of May 2024, Enterprise Value is likely to grow to about 64.1 M, while Selling General Administrative is likely to drop about 9.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 18.7K | 263K | 236.7K | 224.9K | Depreciation And Amortization | 140.2K | 423K | 546K | 350.3K |
EnVVeno Medical fundamental ratios Correlations
Click cells to compare fundamentals
EnVVeno Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
EnVVeno Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 3.4M | 10.5M | 57.7M | 41.7M | 48.6M | 51.1M | |
Other Current Liab | 333.4K | 1.1M | 60.1K | 568K | 1.0M | 901.0K | |
Total Current Liabilities | 1.9M | 3.2M | 1.6M | 1.5M | 1.4M | 2.3M | |
Total Stockholder Equity | 989.9K | 7.1M | 54.4M | 38.7M | 46.2M | 48.5M | |
Property Plant And Equipment Net | 1.2M | 938.9K | 2.6M | 2.2M | 1.7M | 1.1M | |
Net Debt | (450.6K) | (8.5M) | (52.7M) | (2.8M) | (2.2M) | (2.3M) | |
Retained Earnings | (56.2M) | (65.3M) | (81.9M) | (106.5M) | (130.0M) | (123.5M) | |
Accounts Payable | 1.2M | 1.4M | 560.1K | 648K | 427K | 705.4K | |
Cash | 1.3M | 9.3M | 54.7M | 4.6M | 3.6M | 3.4M | |
Non Current Assets Total | 2.0M | 968.8K | 2.7M | 2.2M | 1.7M | 1.8M | |
Cash And Short Term Investments | 1.3M | 9.3M | 54.7M | 39.0M | 46.4M | 48.7M | |
Common Stock Shares Outstanding | 630.4K | 1.3M | 8.7M | 11.2M | 12.3M | 12.9M | |
Liabilities And Stockholders Equity | 3.4M | 10.5M | 57.7M | 41.7M | 48.6M | 51.1M | |
Non Current Liabilities Total | 567.9K | 253.7K | 1.7M | 1.4M | 1.1M | 1.5M | |
Other Current Assets | 116.6K | 234.5K | 312.4K | 392K | 511K | 536.6K | |
Other Stockholder Equity | 57.2M | 72.4M | 136.3M | 145.2M | 176.2M | 185.0M | |
Total Liab | 2.4M | 3.4M | 3.3M | 2.9M | 2.4M | 3.7M | |
Total Current Assets | 1.4M | 9.6M | 55.0M | 39.4M | 46.9M | 49.3M | |
Short Term Debt | 288.7K | 626.9K | 291.1K | 314K | 338K | 619.4K | |
Common Stock | 117.0 | 179.0 | 25.0 | 95.0 | 85.5 | 82.17 | |
Net Tangible Assets | 989.9K | 7.1M | 54.4M | 38.7M | 44.5M | 46.8M | |
Net Invested Capital | 989.9K | 7.4M | 54.4M | 38.7M | 46.2M | 48.5M | |
Net Working Capital | (452.4K) | 6.4M | 53.5M | 37.9M | 45.6M | 47.8M | |
Property Plant Equipment | 1.2M | 938.9K | 2.6M | 521K | 599.2K | 968.9K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for EnVVeno Stock analysis
When running EnVVeno Medical's price analysis, check to measure EnVVeno Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EnVVeno Medical is operating at the current time. Most of EnVVeno Medical's value examination focuses on studying past and present price action to predict the probability of EnVVeno Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EnVVeno Medical's price. Additionally, you may evaluate how the addition of EnVVeno Medical to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Stocks Directory Find actively traded stocks across global markets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is EnVVeno Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.63) | Return On Assets (0.37) | Return On Equity (0.58) |
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.